Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension
© 2015 by The North American Menopause Society. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. Objective: Endometrial spotting or bleeding is a common adverse effect among women taking continuouscombined estrogen-progestin therapy. The renin- angiotensin-aldosterone system plays a...
Saved in:
Main Authors: | Intira Sriprasert, Hind Beydoun, Vanessa Barnabei, Rami Nassir, Andrea Z. LaCroix, David F. Archer |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942509445&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54804 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension
by: Intira Sriprasert, et al.
Published: (2018) -
A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women
by: Dinh A., et al.
Published: (2015) -
Etiologies for postmenopausal bleeding and diagnostic values of endometrial biopsy
by: Orawin Vallibhakara, et al.
Published: (2019) -
Use of vaginosonographic measurements of endometrial thickness in the identification of abnormal endometrium in peri- and postmenopausal bleeding
by: Tongsong T., et al.
Published: (2014) -
Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: A prospective study
by: Manee Rattanachaiyanont, et al.
Published: (2018)